adjuvant cancer chemotherapydevelopment of a dosage schedule for adjuvant cancer chemotherapyin surgical casesan account is given of the developmentof a dosage schedule for adjuvant can-cer chemotherapy for surgical patients.this treatment was administered fortwo purposes:as an adjuvant to radical surgeryto reduce the risk of blood-bornemetastases.as a palliative measure for non-ra-dically operated and inoperable pa-tients.for these purposes 3 dosage levelswere fixed:a maximum tolerated dose for ad-juvant therapy.a maximum tolerated dose for pa-renteral palliative therapy.a maximum tolerated dose for oralpalliative therapy.for this treatment the authors used2 antimitotics, sp-i and sp-g, both ofwhich are podophyllin derivatives.